Cancers
by Indication for Examination for 714,984 Diagnostic Mammography Examinations
from 1996 - 2005
| |
Work-Up of Abnormal Screening Examination
N=232,678 |
Short-Interval Follow-Up
N=163,155 |
Evaluation of Breast Problem/No Lump or Lump Unknown
N=202,490 |
Evaluation of Breast Problem/Palpable Lump
N=116,661 |
All Diagnostic Examinations
N=714,984 |
| All
Cancers |
9,013 |
1,482 |
4,023 |
6,847 |
21,365 |
| Cancer
diagnosis rate (per 1000) |
38.7 |
9.1 |
19.9 |
58.7 |
29.9 |
| Cancer
histology |
|
|
|
|
|
| DCIS |
2,346 (26.0) |
424 (28.6) |
513 (12.8) |
312 (4.6) |
3,595 (16.8) |
| All invasive |
6,667 (74.0) |
1,058 (71.4) |
3,510 (87.2) |
6,535 (95.4) |
17,770 (83.2) |
| Invasive
cancer size |
|
|
|
|
|
| Invasive, 1-5 mm |
723 (12.2) |
148 (15.9) |
197 (6.2) |
160 (2.7) |
1,228 (7.8) |
| Invasive, 6-10 mm |
1,713 (28.9) |
277 (29.8) |
479 (15.2) |
453 (7.8) |
2,922 (18.5) |
| Invasive, 11-15 mm |
1,587 (26.8) |
220 (23.6) |
662 (21.0) |
1,020 (17.5) |
3,489 (22.0) |
| Invasive, 16-20 mm |
808 (13.6) |
113 (12.1) |
541 (17.2) |
1,074 (18.4) |
2,536 (16.0) |
| Invasive, >20 mm |
1,095 (18.5) |
173 (18.6) |
1,275 (40.4) |
3,119 (53.5) |
5,662 (35.8) |
| Invasive, size unknown |
741 |
127 |
356 |
709 |
1,933 |
| Invasive, mean size (mm) |
16.2 |
16.0 |
23.5 |
27.1 |
21.7 |
| Invasive, median size (mm) |
13 |
12 |
19 |
22 |
17 |
| Minimal
cancer |
4,782 (57.8) |
849 (62.7) |
1,189 (32.4) |
925 (15.1) |
7,745 (39.9) |
| Axillary
lymph node status (invasive cancers) |
|
|
|
|
|
| Node negative |
4,976 (79.6) |
782 (82.1) |
2,097 (62.7) |
3,623 (58.3) |
11,478 (68.5) |
| Node positive |
1,273 (20.4) |
170 (17.9) |
1,247 (37.3) |
2,587 (41.7) |
5,277 (31.5) |
| Nodal status unknown |
418 |
106 |
166 |
325 |
1,015 |
| Cancer
stage |
|
|
|
|
|
| Stage 0 |
2,346 (28.5) |
424 (32.5) |
513 (14.3) |
312 (5.3) |
3,595 (18.9) |
| Stage I |
4,109 (49.9) |
616 (47.2) |
1,373 (38.3) |
1,868 (31.8) |
7,966 (41.9) |
| Stage II |
1,582 (19.2) |
232 (17.8) |
1,325 (37.0) |
2,909 (49.5) |
6,048 (31.8) |
| Stage III |
141 (1.7) |
24 (1.8) |
262 (7.3) |
564 (9.6) |
991 (5.2) |
| Stage IV |
50 (0.6) |
10 (0.8) |
108 (3.0) |
228 (3.9) |
396 (2.1) |
| Stage unknown |
785 |
176 |
442 |
966 |
2,369 |
*
Cancers = The number of cancers diagnosed within 1 year following
an examination with an abnormal interpretation (BI-RADS 4 or 5).
† Numbers in parentheses are percentages
of all cancers.
‡ Numbers in parentheses
are percentages of invasive cancers of known size.
§ Minimal cancer = DCIS or invasive cancer
<= 10 mm; numbers in parentheses are percentages of DCIS + invasive cancer
of known size.
|| Numbers in parentheses are percentages
of invasive cancers of known nodal status.
# Numbers in parentheses are percentages
of DCIS + invasive cancers of known stage.
The following source must be cited when reproducing this table: NCI-funded Breast
Cancer Surveillance Consortium co-operative agreement (U01CA63740, U01CA86076, U01CA86082,
U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040). Downloaded xx/xx/xx from the
Breast Cancer Surveillance Consortium Web site - http://breastscreening.cancer.gov/data/benchmarks/diagnostic/table4.html
[Return to Performance Benchmarks for Diagnostic Mammography]
|
